Get started
Author

RYOTA NAKAMURA

ORCID: 0000-0002-0192-6185
Observed ORCID: 0000-0002-0192-6185
OpenAlex ID: A5010212863
Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical Outcomes
2022 · RYOTA NAKAMURA, SATOSHI YONEYAMA, et al. · Anticancer Research · 6
Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer
2024 · SATOSHI ANO, NORIHIRO KIKUCHI, et al. · Anticancer Research · 4
Patient Age andEGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study
2024 · YOSUKE MAEZAWA, MANATO TAGUCHI, et al. · Anticancer Research · 2
Prognostic Impact of Preoperative Assessment of Muscle Mass and Strength in Surgically Resected Lung Cancer
2024 · SHUSUKE KURIHARA, RYOTA NAKAMURA, et al. · Anticancer Research · 2
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
2023 · TOMOHIRO TAMURA, TAKESHI NUMATA, et al. · Anticancer Research · 2
Leptomeningeal Metastasis in Patients With EGFR-positive NSCLC: A Propensity-matched Retrospective Study of Patients With EGFR-negative NSCLC
2026 · HIROAKI SATOH, KUNIHIKO MIYAZAKI, et al. · Anticancer Research · 1
Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)
2023 · SHINICHIRO OKAUCHI, GEN OHARA, et al. · In Vivo · 1
PDF
Works count: 7
Citation count: 18
H-index: 2
I10-index:
Year
Topic
Type